Evidence map›Paper›PMID 20082185›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2010

High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer.

Hendrik Andreas Wolff, Jochen Gaedcke, Klaus Jung, Robert Michael Hermann, Hilka Rothe, Markus Schirmer, Torsten Liersch, Markus Karl Alfred Herrmann, Steffen Hennies, Margret Rave-Fränk and 2 more

Registry-linked trialAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03034473 (Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC II-IV, With a 5-FU-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03034473 naunknown statusnot on this mapstarted 2011, after this paper: background citation

Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC II-IV, With a 5-FU-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.

TypeinterventionalSponsorUniversity Medical Center GoettingenRan2011 to 2024Enrolled200ConditionsLocally Advanced Rectal CancerArmsTranslational Research and multimodal treatment
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Clinical outcome of rectal cancer in patients ≥ 80 years treated in southern France (PACA region) between 2002 and 2005.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2012
    Article
  12. Radiotherapy with and without temozolomide in elderly patients with glioblastoma.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2012
    Article
  13. Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hendrik Andreas WolffDepartment of Radiotherapy and Radiooncology, University Medicine Göttingen, Göttingen, Germany.
Jochen GaedckeDepartment of Surgery, University Medicine Göttingen, Göttingen, Germany.
Klaus JungDepartment of Medical Statistics, University Medicine Göttingen, Göttingen, Germany.
Robert Michael HermannDepartment of Radiotherapy and Radiooncology, University Medicine Göttingen, Göttingen, Germany.
Hilka RotheDepartment of Pathology, University Medicine Göttingen, Göttingen, Germany.
Markus SchirmerDepartment of Clinical Pharmacology, University Medicine Göttingen, Göttingen, Germany.
Torsten LierschDepartment of Surgery, University Medicine Göttingen, Göttingen, Germany.
Markus Karl Alfred HerrmannDepartment of Radiotherapy and Radiooncology, University Medicine Göttingen, Göttingen, Germany.
Steffen HenniesDepartment of Radiotherapy and Radiooncology, University Medicine Göttingen, Göttingen, Germany.
Margret Rave-FränkDepartment of Radiotherapy and Radiooncology, University Medicine Göttingen, Göttingen, Germany.
Clemens Friedrich HessDepartment of Radiotherapy and Radiooncology, University Medicine Göttingen, Göttingen, Germany.
Hans ChristiansenDepartment of Radiotherapy and Radiooncology, University Medicine Göttingen, Göttingen, Germany. hchrist@gwdg.de.
Universitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo test for a possible correlation between high-grade acute organ toxicity during preoperative radiochemotherapy and complete tumor regression after total mesorectal excision in multimodal treatment of locally advanced rectal cancer. PATIENTS AND

methodsFrom 2001 to 2008, 120 patients were treated. Preoperative treatment consisted of normofractionated radiotherapy at a total dose of 50.4 Gy, and either two cycles of 5-fluorouracil (5-FU) or two cycles of 5-FU and oxaliplatin. Toxicity during treatment was monitored weekly, and any toxicity CTC (Common Toxicity Criteria) >or= grade 2 of enteritis, proctitis or cystitis was assessed as high-grade organ toxicity for later analysis. Complete histopathologic tumor regression (TRG4) was defined as the absence of any viable tumor cells.

resultsA significant coherency between high-grade acute organ toxicity and complete histopathologic tumor regression was found, which was independent of other factors like the preoperative chemotherapy schedule. The probability of patients with acute organ toxicity >or= grade 2 to achieve TRG4 after neoadjuvant treatment was more than three times higher than for patients without toxicity (odds ratio: 3.29, 95% confidence interval: [1.01, 10.96]).

conclusionAcute organ toxicity during preoperative radiochemotherapy in rectal cancer could be an early predictor of treatment response in terms of complete tumor regression. Its possible impact on local control and survival is under further prospective evaluation by the authors' working group.

Indexed as

Neoadjuvant TherapyAdultAgedAged, 80 and overAntimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyCystitisDisease ProgressionDose-Response Relationship, DrugDrug Administration ScheduleEnteritisFemaleFluorouracilFollow-Up StudiesHumansAntimetabolites, AntineoplasticFluorouracilOrganoplatinum CompoundsOxaliplatin

Identifiers

PMID20082185
OpenAlexW1529839584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.